Miss Maggie Liu
Address:
Economic Development Zone, Guang'an, Sichuan, China
Telephone:
Zip Code:
Fax:
| Please sign in to view contact details |
Account Registered in:
2025
Business Range:
Agriculture & Food, Health & Medicine
Business Type:
Manufacturer/Factory
Company Introduction
Production Capacity
Sichuan Dingke Pharmaceuticals Co., Ltd. Was established in Sep. 2022 and is a high-tech enterprise majority-owned by Chongqing Xieran Pharma. We specialize in the R&D, manufacturing, and sales of pharmaceutical
Intermediates, active pharmaceutical ingredients (APIs), finished dosages, and cosmetic raw materials.
Guided by our core values of dedication, resilience, innovation, and shared
...
Intermediates, active pharmaceutical ingredients (APIs), finished dosages, and cosmetic raw materials.
Guided by our core values of dedication, resilience, innovation, and shared
...
Sichuan Dingke Pharmaceuticals Co., Ltd. Was established in Sep. 2022 and is a high-tech enterprise majority-owned by Chongqing Xieran Pharma. We specialize in the R&D, manufacturing, and sales of pharmaceutical
Intermediates, active pharmaceutical ingredients (APIs), finished dosages, and cosmetic raw materials.
Guided by our core values of dedication, resilience, innovation, and shared
Success, we are deeply focused on advancing the field of APIs and specialized fine chemicals. Our mission is to become a leading supplier of specialty APIs in
Southwest China and a benchmark enterprise in the fields of orthopedics,
Dermatology, and neuropsychiatric medications across the domestic market.
Our manufacturing facility is located in the Yuechi County Pharmaceutical Industrial Park in Guang'an City, Sichuan Province. The site spans approximately 148, 666
Square meters, with a total planned investment of around USD 415 million. The
Project follows a phased construction strategy aligned with a comprehensive
Development plan, with full completion expected within five years.
Once fully operational, the facility will house 11 production workshops for APIs and
Intermediates, along with one integrated formulation workshop. The site is designed to achieve an annual production capacity of over 5, 000 metric tons of APIs and
Pharmaceutical intermediates. Phase I of the project is scheduled to be completed
And enter operation by August 2025, with commercial production and sales targeted by the end of the year.
Intermediates, active pharmaceutical ingredients (APIs), finished dosages, and cosmetic raw materials.
Guided by our core values of dedication, resilience, innovation, and shared
Success, we are deeply focused on advancing the field of APIs and specialized fine chemicals. Our mission is to become a leading supplier of specialty APIs in
Southwest China and a benchmark enterprise in the fields of orthopedics,
Dermatology, and neuropsychiatric medications across the domestic market.
Our manufacturing facility is located in the Yuechi County Pharmaceutical Industrial Park in Guang'an City, Sichuan Province. The site spans approximately 148, 666
Square meters, with a total planned investment of around USD 415 million. The
Project follows a phased construction strategy aligned with a comprehensive
Development plan, with full completion expected within five years.
Once fully operational, the facility will house 11 production workshops for APIs and
Intermediates, along with one integrated formulation workshop. The site is designed to achieve an annual production capacity of over 5, 000 metric tons of APIs and
Pharmaceutical intermediates. Phase I of the project is scheduled to be completed
And enter operation by August 2025, with commercial production and sales targeted by the end of the year.
Factory Address:
Economic Development Zone, Guang'an, Sichuan, China